Retinal toxicity involving the macula as a complication of the antiretroviral protease inhibitor ritonavir has been described in a few cases. We report retinal pigment epitheliopathy involving the macula with a bull's eye pattern in a 36-year-old man with well-controlled HIV receiving ritonavir with gradually progressive bilateral vision loss.
WhitcupS.M., ButlerK.M., CarusoR.Retinal toxicity in human immunodeficiency virus-infected children treated with 2′,3′-dideoxyinosine.Am J Ophthalmol1992; 113: 1–7.
6.
GuzakR., RodmanJ., PizzimentiJ.Cystoid macular edema as a result of immune-recovery uveitis.Optom Vis Sci2011; 88: E344–E351.
7.
HartleyD.P., DaiX., YabutJ.Identification of potential pharmacological and toxicological targets differentiating structural analogs by a combination of transcriptional profiling and promoter analysis in LS-180 and Caco-2 adenocarcinoma cell lines.Pharmacogenet Genomics2006; 16: 579–599.
8.
VadlapatlaR.K., VadlapudiA.D., PalD., MukherjiM., MitraA.K.Ritonavir inhibits HIF-1α-mediated VEGF expression in retinal pigment epithelial cells in vitro.Eye (Lond)2014; 28: 93–101.
